Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Conditions
Metastatic Malignant Solid Neoplasm · Metastatic Melanoma · Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 · Pathologic Stage IV Cutaneous Melanoma AJCC v8 · Recurrent Malignant Solid Neoplasm · Refractory Malignant Solid Neoplasm · Uveal Melanoma · Acral Melanoma · Neuroendocrine Tumors · Paraganglioma · Pheochromocytoma · Adrenocortical Carcinoma · Pancreatic Neuroendocrine Tumor · Thyroid Cancer · Breast Cancer · Lung Adenocarcinoma · Head and Neck Squamous Cell Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope, Duarte, California, United States
Contact: Principal Investigator (Yan Xing, MD, Phd)UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Contact: Principal Investigator (Antoni Ribas, MD, PhD)Stanford Cancer Institute, Stanford, California, United States
Contact: Principal Investigator (Allison Betof Warner, MD, PhD)
Study leads
Allison Betof Warner, MD, PhD
Principal Investigator
Stanford University
Antoni Ribas, MD, PhD
Principal Investigator
University of California, Los Angeles
Yan Xing, MD, PhD
Principal Investigator
City of Hope Medical Center